Scientific Research & Technology

DaAn Gene has taken on nearly 30 key research projects of state, province and ministries, and developed independently the gene diagnostic technologies β€” Fluorescence Quantitative PCR (FQ-PCR).

FQ-PCR combines gene amplification, molecule hybridization with fluorescence physics, conducts the whole process of DNA amplification and PCR products analysis in an enclosed tube, and realizes real-time detection as well as auto analysis under computer control. As a result, the cross-contamination of conventional PCR products and incapacity of quantifying can be colved fundamentally. Furthermore, the specificity and sensitivity are increased remarkably, all of which reflect the highest level of gene diagnostic technology in China. This new PCR technology has not only an advantage in diagnosing infectious diseases, but also a wider prospect of application in the fields of tumor and genetic diseases diagnosis.

DaAn Gene was entrusted with a national mission at the critical moment, like SARS and Dengue indulged in willful persecution in China, or the MEAS and Ebola virus in the world, and developed firstly the FQ-PCR kit for early detection of SARS-corona virus (SARS-CoV), Dengue, Ebola upon the platform of FQ-PCR, got New Drug Certificate and Tentative Manufacture Approval from CFDA. The production of these kits provided solid technological barrier against the spreading of SARS and Dengue.

With 20 years in development, DaAn Gene has an efficient technology and management team of over 800 staff, including more than 100 doctors, graduates and overseas scientists. The company is also Ministry of Health Pharmaceutical Engineering Biotechnology Research Center, Guangdong Province Clinical Molecular Diagnostics Engineering Laboratory, Institute of Biotechnology, Sun Yat-sen University, Sun Yat-sen University Tissue Typing Center, Guangzhou Antibody Egineering Technology Research Center, Guangzhou Molecular Diagnostics Engineering Technology Center and many other research institutions. It has the first self-patent fluorescence quantitative polymerase chain reaction (FQ-PCR) diagnostic reagents intellectual property core technology.

DaAn Gene is leading in DNA research, it has bear more than ten national key scientific and technological projects and 20+ municipal key or major science and technology projects. The company's research and development by quantitative PCR (FQ-PCR) technology and products has been included in the national key research projects, national high-tech industry demonstration projects, national high-tech industrial development project, the National Torch Program, "Nine five-year", "ten-five year", "Eleventh Five-Year" national Science and Technology (research) program, the "863" project, major projects national Key Basic Research and Development Program (973 Program), the National Communicable Disease Control, Drug Discovery major projects, health Key research, Guangdong Province, Guangzhou City, the focus of research and major research projects, including a national key support and encourage projects. The company reported a total of invention patents, utility model patents hundred items, has authorized more than twenty, has won the National Science and Technology Progress Award (two), China Patent Gold, China Patent Excellence Award, the National Hi-Tech Industrial Decade Achievement Award, Guangdong Province scientific and technological progress, Guangdong Province Science and Technology Progress Award, Ministry of Education, Science and Technology progress Award, the Guangzhou Municipal Science and Technology progress Award more than 10 national and provincial awards. Companies were identified as outstanding high-tech enterprises in Guangdong Province, Guangdong Province innovative enterprises and national enterprises and intellectual property pilot units.